Cerecor Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Cerecor Inc
TickerAVTX
CIK #0001534120
CUSIP05338F108
SectorLife Sciences - Pharmaceutical Preparations
Address400 E Pratt St Suite 606, Baltimore, MD 21202
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Avalo Therapeutics Inc 2024-04-09 130.6 M Exemption: 506(b) · Remaining: $69,375,000 · Duration: One year or less · Finder's Fee: $6,937,500 · Revenue: Decline to Disclose
Cerecor Inc 2017-05-08 5.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001534120] 10-K
[0001534120] 10-Q
[0001534120] 3
[0001534120] 4
[0001534120] 8-K
[0001534120] D
[0001534120] SC 13D
[0001534120] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Commodore Capital LP Avalo Therapeutics Inc [2026-06-18] 0.0
Deep Track Capital LP Avalo Therapeutics Inc [2026-05-29] 0.0
Point72 Asset Management LP Avalo Therapeutics Inc [2026-05-26] 0.0
Avoro Capital Advisors LLC Avalo Therapeutics Inc [2026-05-15] 0.0
T Rowe Price Investment Management Inc Avalo Therapeutics Inc [2026-05-15] 0.0
TCG Crossover GP II LLC Avalo Therapeutics Inc [2026-05-12] 0.0
Logos Global Management LP Avalo Therapeutics Inc [2026-04-01] 0.0
FMR LLC Avalo Therapeutics Inc [2026-03-06] 0.0
Millennium Management LLC Avalo Therapeutics Inc [2026-02-24] 0.0
Millennium Management LLC Avalo Therapeutics Inc [2026-02-17] 0.0
SilverArc Capital Management LLC Avalo Therapeutics Inc [2026-02-10] 0.0
Millennium Management LLC Avalo Therapeutics Inc [2026-02-10] 0.0
Millennium Management LLC Avalo Therapeutics Inc [2026-02-03] 0.0
Balyasny Asset Management LP Avalo Therapeutics Inc [2025-11-14] 0.0
Caligan Partners LP Avalo Therapeutics Inc [2025-11-14] 0.0
SilverArc Capital Management LLC Avalo Therapeutics Inc [2025-11-14] 0.0
Vanguard Group Inc Avalo Therapeutics Inc [2025-10-30] 0.0
Point72 Asset Management LP Avalo Therapeutics Inc [2025-08-05] 0.0
Nantahala Capital Management LLC Avalo Therapeutics Inc [2025-05-15] 0.0
Affinity Asset Advisors LLC Avalo Therapeutics Inc [2024-12-31] 0.0
OrbiMed Advisors LLC Avalo Therapeutics Inc [2024-11-14] 0.9
Ikarian Capital LLC Avalo Therapeutics Inc [2024-10-07] 819410.02
Biotechnology Value Fund L P Avalo Therapeutics Inc [2024-08-23] 5.3
RA Capital Management LP Avalo Therapeutics Inc [2024-08-23] 0.99
Crutcher Patrick J Avalo Therapeutics Inc [2024-08-23] 0.9
Allostery Investments LP Avalo Therapeutics Inc [2024-05-13] 7.6
Emerald BioVentures LLC Avalo Therapeutics Inc [2024-04-23] 5.6
Deep Track Capital LP Avalo Therapeutics Inc [2024-04-05] 0.99
Venrock Healthcare Capital Partners III LP Avalo Therapeutics Inc [2023-02-17] 0.99
Great Point Partners LLC Avalo Therapeutics Inc [2023-02-13] 7.12
Caissa Capital Management Ltd Avalo Therapeutics Inc [2022-05-17] 3.63
Point72 Asset Management LP Avalo Therapeutics Inc [2021-09-21] 5.4
Nantahala Capital Management LLC Cerecor Inc [2021-02-16] 8.3
Cerecor Inc Aytu Bioscience Inc [2020-04-27] 0.0
Opaleye Management Inc Cerecor Inc [2018-10-03] 11.0
Baradaran Sharyar Cerecor Inc [2018-02-12] 2.59
Moscato Robert Jr Cerecor Inc [2017-11-28] 8.3
Jones Randal Cerecor Inc [2017-11-27] 8.3
Armistice Capital LLC Cerecor Inc [2017-05-08] 22.8
Baradaran Sharyar Cerecor Inc [2016-08-02] 5.2
Apple Tree Partners IV LP Cerecor Inc [2016-02-12] 6.9
New Enterprise Associates 14 LP Cerecor Inc [2016-02-01] 6.9
Form 3/4/5 Filer 2011 - 2026
Jain Rita
Avalo Therapeutics Inc
Lind Kevin Robert
Doyle Mittie
Philip Ron M
Sullivan Christopher Ryan
Varki Paul
Riley Jennifer
Heffernan Michael Thomas
Truex Samantha
Kantoff Aaron
Kaplan Gilla
Neil Garry Arthur
Chan Mitchell
Goldman Jonathan
Boyd Taylor
Almenoff June Sherie
Persson Magnus
Armistice Capital Master Fund Ltd
Boyd Steven
Armistice Capital LLC
Caissa Capital Management ltd
Miller Joseph M
Smolinski Stephen
Harrell James Archie Jr
Wilkins H Jeffrey
Greenway Schond L
Gutry Phil
Bruhn Suzanne Louise
Maher Illya Keith
Cola Michael F
Barer Sol J
Aytu Biopharma Inc
Calias Pericles
Pedder Simon
Hacksell Uli
Phillips Matthew V
Schmidt Keith
Greenleaf Peter
Crutcher Patrick J
Blech Isaac
Jones Randal
Fremantle LLC
LRS International LLC
Moscato Robert Jr
Bauer Eugene A
Morris Mariam E
Kaiser John Joseph
Aasen Thomas H
Marcus Ronald
Sheldon Behshad
Mott David M
NEA Partners 14 LP
New Enterprise Associates 14 LP
NEA 14 GP Ltd
Barrett M James
Barris Peter J
Baskett Forest
Florence Anthony A Jr
Kerins Patrick J
Kolluri Krishna Kittu
Sandell Scott D
Sonsini Peter W
Viswanathan Ravi
Weller Harry R
Paterson Blake M
Harrison Seth Loring
ATP Life Science Ventures LP
ATP III GP Ltd
MPM BioVentures V LP
MPM BioVentures V GP LLC
Kailian Vaughn M
Foley Todd
Evnin Luke
Gadicke Ansbert
Scopa James Paul
MPM BioVentures V LLC
MPM Asset Management Investors BV5 LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Chan Mitchell
Restricted Stock Units · derivative
2026-03-28 Option exercise 3,166 $0.00
Goldman Jonathan
Common Stock
2026-03-28 Option exercise 3,166
Neil Garry Arthur
Common Stock
2026-03-28 Tax withheld 21,892 $13.89 304,080
Neil Garry Arthur
Common Stock
2026-03-28 Option exercise 64,866
Goldman Jonathan
Restricted Stock Units · derivative
2026-03-28 Option exercise 3,166 $0.00
Sullivan Christopher Ryan
Common Stock
2026-03-28 Tax withheld 8,241 $13.89 114,467
Truex Samantha
Restricted Stock Units · derivative
2026-03-28 Option exercise 3,166 $0.00
Sullivan Christopher Ryan
Restricted Stock Units · derivative
2026-03-28 Option exercise 24,200 $0.00
Kaplan Gilla
Restricted Stock Units · derivative
2026-03-28 Option exercise 3,166 $0.00
Kaplan Gilla
Common Stock
2026-03-28 Option exercise 3,166
Kantoff Aaron
Restricted Stock Units · derivative
2026-03-28 Option exercise 3,166 $0.00
Kantoff Aaron
Common Stock
2026-03-28 Option exercise 3,166
Sullivan Christopher Ryan
Common Stock
2026-03-28 Option exercise 24,200
Truex Samantha
Common Stock
2026-03-28 Option exercise 3,166
Chan Mitchell
Common Stock
2026-03-28 Option exercise 3,166
Neil Garry Arthur
Restricted Stock Units · derivative
2026-03-28 Option exercise 64,866 $0.00
Doyle Mittie
Common Stock
2026-03-16 Sell 25,492 $16.15 411,696
Doyle Mittie
Common Stock
2026-03-16 Option exercise 19,500 $12.65 246,675
Doyle Mittie
Stock Option (Right to Buy) · derivative
2026-03-16 Option exercise 19,500 $0.00
Doyle Mittie
Common Stock
2026-03-16 Option exercise 5,992 $8.04 48,176
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 101 32,209,613
2025-12-31 85 20,385,017
2025-09-30 66 15,470,958
2025-06-30 37 7,843,045
2025-03-31 35 8,255,062
2024-12-31 34 7,490,560
2024-09-30 30 6,656,940
2024-06-30 22 771,104
2024-03-31 19 87,587
2023-12-31 13 23,012
2022-06-30 55 69,415,201
2022-03-31 71 77,734,374
Form 13F Holdings
Firm Period DFND Voting Shares
Moody Aldrich Partners LLC [2026-06-30] SOLE 54,700 125,582
PFS Partners LLC [2026-06-30] SOLE 0 2,000
Fortitude Family Office LLC [2026-06-30] SOLE 30 30
Activest Wealth Management [2026-06-30] SOLE 0 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com